Broncho-Vaxom Adult 7mg 10 Capsules | Indications & Buy Online

Broncho-Vaxom Adult 7mg is an advanced immunomodulatory medication designed to bolster the body's natural defenses against recurrent infections of the respiratory tract. Developed in Switzerland, it contains a standardized blend of lyophilized bacterial lysates that act as an "oral vaccine," stimulating the immune system to recognize and fight common bacterial pathogens more effectively. This medication is highly beneficial for adults suffering from chronic bronchitis or individuals prone to seasonal respiratory complications. By enhancing both innate and adaptive immunity, it significantly reduces the frequency, duration, and severity of acute infectious episodes and decreases the overall dependency on intensive antibiotic therapy.

Composition and Active Substance

Each capsule of Broncho-Vaxom Adult contains:

• Active Substance: 7 mg of lyophilized bacterial lysates, including Haemophilus influenzae, Streptococcus pneumoniae, Klebsiella pneumoniae, Klebsiella ozaenae, Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, and Moraxella catarrhalis.

• Inactive Ingredients: Anhydrous propyl gallate, sodium glutamate, mannitol, pregelatinized starch, magnesium stearate, and a capsule shell composed of gelatin, indigotine, and titanium dioxide.

Pharmacological Action

The pharmacological efficacy of Broncho-Vaxom Adult 7mg is rooted in its immunostimulating mechanism. Upon oral administration, the bacterial lysates interact with the Peyer’s patches in the intestinal mucosa. This interaction triggers a cascade of immune responses:

1. Cellular Activation: It increases the metabolic activity and phagocytic capacity of macrophages and polymorphonuclear neutrophils.

2. Antibody Stimulation: It elevates the levels of Secretory Immunoglobulin A (sIgA) in the respiratory mucosa, providing a first-line defense against bacterial adhesion.

3. Cytokine Modulation: It promotes the circulation of T-lymphocytes and increases the production of protective cytokines like Interferon-gamma and Interleukin-2. This comprehensive activation ensures that the adult respiratory system is better prepared to neutralize pathogens before they lead to full-scale inflammation or infection.

Indications for Use

• Prophylactic Care: Prevention of recurrent infections of the upper and lower respiratory tract (bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, and otitis).

• Acute Episode Support: Used as a co-therapy alongside antibiotics and expectorants to speed up recovery during acute respiratory infections.

• Chronic Conditions: Reducing the frequency of exacerbations in patients with chronic obstructive pulmonary disease (COPD) or chronic bronchitis.

Contraindications

• Hypersensitivity: Known allergy to the active bacterial lysates or any excipient in the formula.

• Autoimmune Disorders: Patients with established autoimmune diseases should avoid use unless specifically directed by a specialist.

• Acute Intestinal Infections: Should not be used during acute gastrointestinal distress that might interfere with absorption.

Dosage and Administration

The therapeutic regimen for adults and adolescents over 12 years of age:

• Preventative Course: 1 capsule daily on an empty stomach for 10 consecutive days per month. This cycle should be repeated for 3 consecutive months.

• Treatment of Acute Stages: 1 capsule daily on an empty stomach until symptoms resolve (minimum of 10 days). If antibiotics are required, Broncho-Vaxom should be taken from the first day of antibiotic treatment.

Special Administration Tips

To ensure maximum bioavailability, the capsule should be swallowed whole with a glass of water in the morning, 30 minutes before breakfast. Consistently taking the medication at the same time each day helps maintain a steady immune-stimulating effect.

Side Effects and Adverse Reactions

Broncho-Vaxom Adult is generally well-tolerated, but some patients may experience:

• Gastrointestinal: Dyspepsia, nausea, or mild abdominal pain.

• Dermatological: Rare instances of skin rash, erythema, or hives.

• Respiratory: A temporary increase in cough or slight shortness of breath as the immune system responds.

• General: Occasional fatigue or low-grade fever during the initial days of the cycle.

Special Precautions & Warnings

• Pregnancy and Lactation: Use during pregnancy (especially the first trimester) and breastfeeding is generally not recommended unless the clinical benefit outweighs the potential risk. Consult a physician first.

• Preparation Interactions: There are no known negative interactions with other preparations. It can be safely combined with antibiotics, anti-inflammatory preparations, and mucolytics.

• Immune Reactions: If a patient develops a persistent skin reaction or high fever, the treatment should be stopped immediately.

Storage Conditions and Shelf Life

• Store in a cool, dry place at a temperature not exceeding 25°C.

• Keep the capsules in their original blister pack to protect them from light and moisture.

• Shelf Life: 5 years. Do not use after the expiry date indicated on the packaging.

• Keep out of the reach and sight of children.